Therefore, go and make disciples of all the nations, baptizing them in the name of the Father and the Son and the Holy Spirit. Teach these new disciples to obey all the commands I have given you. And be sure of this: I am with you always, even to the end of the age. [Matthew 28:19-20 (NLT)]
In 1978, Merck Research Laboratories was approached by a scientist who thought a drug he was developing to treat parasitic infections in animals might be useful in treating a parasitic infection in humans. Called onchocerciasis or river blindness, it is transmitted through the bite of black flies and had no known cure. The pharmaceutical company faced a dilemma. Since onchocerciasis is found only in third world areas, the people needing the medication could never afford to buy it. How could the company expend money to develop a drug they’d never be able to sell? Nevertheless, they did and, in 1987, Merck announced that, for as long as was necessary, they would give away the drug (Mectizan®) for the treatment of onchocerciasis to any country that needed it. Eleven years later, they expanded their commitment and started donating Mectizan® for the treatment of Lymphatic filariasis, a mosquito-transmitted disease which can develop into elephantiasis. Since 1987, more than a billion treatments have been donated to thirty-three countries and the World Health Organization forecasts that both diseases could be eradicated by 2020.
Typically, in business, if there’s no chance for profit, there’s no chance for the project. In the case of Mectizan®, however, Merck saw the company’s primary goal as getting the drug to the people who needed it rather than getting a return on their investment. This mindset goes back to a statement by George Merck in 1933 that the company’s mission was to develop scientific breakthroughs to benefit humanity. In 1950, he elaborated by saying, “Medicine is for the people. It is not for the profits.” Merck’s CEO in 1978, Dr. Roy Vagelos, further clarified the company’s mission by directing its scientists to put medical needs before profits and to think of their work as a quest to alleviate worldwide human disease and suffering.
Jesus gave us what’s known as the Great Commission; recently, our northern church wanted to clarify how it intended to fulfill that command. At a congregational meeting to formulate a mission statement, the story of Merck putting people before profit was shared to illustrate the importance of knowing our purpose and what we will or won’t do to achieve it. It’s not just churches, businesses or charitable foundations, however, that need to articulate their mission. “What is my objective? What have I been called to do and how will I do it?” are questions each of us should ask of ourselves and our families.
In that same 1950 speech, George Merck said, “The all-important question in research, which must be asked constantly, is: what is the right thing to do? … We cannot rest till the way has been found…to bring our finest achievement to everyone.” I’m not in medical research but Merck’s words apply to us all. What is the right thing to do? How can we bring our finest achievements to others? A good place to start is to ask two more questions: “What would Jesus do and how would He do it?”
Do all the good you can, by all the means you can, in all the ways you can, in all the places you can, at all the times you can, to all the people you can, as long as ever you can. [John Wesley]